je.st
news
Gilead CEO John Martin wins 2012 bonus of $3.4 million
2013-02-06 06:41:28| Biotech - Topix.net
Gilead Sciences Inc. Chairman and CEO John Martin snagged a $3.38 million bonus for 2012 - a year in which the HIV drug developer won groundbreaking drug approvals and moved forward with key hepatitis drug trials - and a $1.58 million base salary for 2013.
Tags: john
million
martin
bonus
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||